CDK2 and cancer: Snol-A led CARF-inhibition attenuated its inhibitory effect on p21WAF1 protein in p53-null cancer cells and resulted in growth arrest, mediated by decreased levels of p21WAF1-effector targets including Cyclin A, CDK2, CDK4 and cyclin D1.